Comparison of treatment outcomes and complications of short-term and long-term brachytherapy in patients with cervical cancer
Not Applicable
- Conditions
- Cervical Cancer.Malignant neoplasm of cervix uteri
- Registration Number
- IRCT20200617047815N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 66
Inclusion Criteria
age less than 70 years old
histopathology Adenocarcinoma & squamous cell carcinoma
suitable performance status
Stage 1b-4a
hemoglobin more than 10
Cervical cancer patients
Females
Exclusion Criteria
Recurrent disease
other treatment procedure like surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of cystitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.;The rate of proctitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.;The rate of vaginitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.
- Secondary Outcome Measures
Name Time Method